Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (6827)	7/29/1998 7:15:00 AM
From: Robert K.	Read Replies (1) \| Respond to of 17367

AND......I guess we can chalk up the INCY bpi patents too.............> >>Pat. No.Title1.5,770,694 Genetically engineered BPI variant proteins 2.5,532,216 Neutralization of non-lipopolysaccharide compounds by bactericidal/permeability-increasing protein 3.5,334,584 Recombinant, non-glycosylated bpi protein and uses thereof 4.5,308,834 Treatment of endotoxin-associated shock and prevention thereof using a BPI protein 5.5,234,912 Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof 6.5,171,739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein 7.5,089,274 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders